NIKKEI 225
37,695.75 +67.27 (+0.18%) HANG SENG
17,284.54 +83.27 (+0.48%) CRUDE OIL
83.86 +0.29 (+0.35%) GOLD FUTURES
2,340.70 -1.80 (-0.08%) DOW
38,085.80 -375.12 (-0.98%) Bitcoin GBP
51,382.30 -245.39 (-0.48%)
MEI Pharma, Inc. (MEIP)
After hours:
| Previous close | 3.2600 |
| Open | 3.2600 |
| Bid | 0.0000 x 0 |
| Ask | 0.0000 x 0 |
| Day's range | 3.1000 - 3.2600 |
| 52-week range | 3.1000 - 7.9700 |
| Volume | |
| Avg. volume | 21,403 |
| Market cap | 20.655M |
| Beta (5Y monthly) | 0.64 |
| PE ratio (TTM) | 1.04 |
| EPS (TTM) | N/A |
| Earnings date | N/A |
| Forward dividend & yield | N/A (N/A) |
| Ex-dividend date | 16 Nov 2023 |
| 1y target est | N/A |
- Insider Monkey
12 Most Undervalued Biotech Stocks To Buy According To Hedge Funds
In this article, we discuss 12 most undervalued biotech stocks to buy according to hedge funds. If you want to skip our discussion on the biotech industry, head over to 5 Most Undervalued Biotech Stocks To Buy According To Hedge Funds. Fitch Ratings maintains a Neutral outlook for the global pharmaceutical and biotech industry in […]
- Zacks
MEI Pharma, Inc. (MEIP) Reports Q2 Loss, Misses Revenue Estimates
MEI Pharma, Inc. (MEIP) delivered earnings and revenue surprises of -13.70% and 100%, respectively, for the quarter ended December 2023. Do the numbers hold clues to what lies ahead for the stock?
- Insider Monkey
Is MEI Pharma (MEIP) Attractively Priced?
GreenWood Investors LLC, an investment management firm, released its annual 2023 investor letter. A copy of the same can be downloaded here. 2023 was excellent for the fund’s investors, thanks to the collaborative and constructive engagements, which added immense value to the performance. Despite that, the firm is still seeking more challenges to continue to drive […]
